Mammalian assay for site-specific DNA damage processing using the human H-ras proto-oncogene

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• The H-ras proto-oncogene plays a critical role in cell signaling and cancer development.
• Understanding DNA repair mechanisms is crucial for preventing mutations that lead to oncogene activation.
• Epstein-Barr virus (EBV) vectors offer a stable platform for studying gene function and DNA replication in mammalian cells.

Purpose of the Study:

• To investigate the efficiency of DNA mismatch correction at specific sites within the human H-ras proto-oncogene.
• To determine how different types of nucleotide mismatches (G:T, A:C, T:C) are repaired during DNA replication.
• To establish a system for creating and analyzing gapped heteroduplex (GHD) DNA containing targeted mutations.

Main Methods:

• Construction of gapped heteroduplex (GHD) DNA using an Epstein-Barr virus (EBV) vector containing the H-ras proto-oncogene.
• Introduction of specific single-nucleotide mismatches at codon 12 of the H-ras gene.
• Transfection of GHD DNA into NIH 3T3 cells and selection of hygromycin-resistant colonies.
• Polymerase chain reaction (PCR) amplification and sequencing of the H-ras gene in transfected cells to assess mismatch correction.

Main Results:

• High correction rates of mismatches to the wild-type G:C sequence were observed in NIH 3T3 cells.
• G:T mismatches were corrected with 96.4% efficiency.
• A:C mismatches showed an 87.5% correction rate, while T:C mismatches were corrected with 67% efficiency.

Conclusions:

• The DNA mismatch repair system in NIH 3T3 cells is highly effective at correcting specific mismatches within the H-ras proto-oncogene.
• The efficiency of mismatch correction varies depending on the type of nucleotide mismatch present.
• This study provides insights into the fidelity of DNA replication and repair mechanisms relevant to proto-oncogene maintenance.